Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IM Cannabis (IMCC) Common Equity (2019 - 2026)

IM Cannabis has reported Common Equity over the past 8 years, most recently at -$3.7 million for Q1 2026.

  • For Q1 2026, Common Equity changed N/A year-over-year to -$3.7 million; the TTM value through Mar 2026 reached -$3.7 million, changed N/A, while the annual FY2025 figure was -$2.7 million, 169.85% down from the prior year.
  • Common Equity was -$3.7 million for Q1 2026 at IM Cannabis, down from -$2.7 million in the prior quarter.
  • Across five years, Common Equity topped out at $16.7 million in Q4 2022 and bottomed at -$3.7 million in Q1 2026.
  • The 5-year median for Common Equity is $3.8 million (2024), against an average of $4.9 million.
  • Year-over-year, Common Equity crashed 36.31% in 2023 and then crashed 171.27% in 2025.
  • Over 5 years, Common Equity stood at $16.7 million in 2022, then plummeted by 36.31% to $10.6 million in 2023, then tumbled by 64.69% to $3.8 million in 2024, then plummeted by 171.27% to -$2.7 million in 2025, then plummeted by 37.7% to -$3.7 million in 2026.
  • The last three reported values for Common Equity were -$3.7 million (Q1 2026), -$2.7 million (Q4 2025), and $3.8 million (Q4 2024) per Business Quant data.